Sep 09, 2019 / 05:00PM GMT
Presentation
Sep 09, 2019 / 05:00PM GMT
=====================
Corporate Participants
=====================
* Anne E. White
Eli Lilly and Company - Senior VP & President of Lilly Oncology
* Daniel M. Skovronsky
Eli Lilly and Company - Senior VP & Chief Scientific Officer
* Jacob S. Van Naarden
Loxo Oncology, Inc. - COO
* Kevin Hern
Eli Lilly and Company - VP of IR
* S. Michael Rothenberg
Loxo Oncology, Inc. - VP of Research and Development.
=====================
Conference Call Participants
=====================
* Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst
* Jason Matthew Gerberry
BofA Merrill Lynch, Research Division - MD in US Equity Research
* Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD
* Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
Eli Lilly and Co to Discuss World Conference on Lung Cancer Presentation Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot